205 related articles for article (PubMed ID: 33162531)
1. [Pathology and treatment of multiple myeloma understood from the tumor cell-of-origin perspective].
Tanaka H
Rinsho Ketsueki; 2020; 61(9):1317-1324. PubMed ID: 33162531
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
Franqui-Machin R; Wendlandt EB; Janz S; Zhan F; Tricot G
Oncotarget; 2015 Dec; 6(38):40496-506. PubMed ID: 26415231
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.
Issa ME; Takhsha FS; Chirumamilla CS; Perez-Novo C; Vanden Berghe W; Cuendet M
Clin Epigenetics; 2017; 9():17. PubMed ID: 28203307
[TBL] [Abstract][Full Text] [Related]
4. Concise review: Defining and targeting myeloma stem cell-like cells.
Abe M; Harada T; Matsumoto T
Stem Cells; 2014 May; 32(5):1067-73. PubMed ID: 24449391
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma cancer stem cells.
Gao M; Kong Y; Yang G; Gao L; Shi J
Oncotarget; 2016 Jun; 7(23):35466-77. PubMed ID: 27007154
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.
Shay G; Hazlehurst L; Lynch CC
J Mol Med (Berl); 2016 Jan; 94(1):21-35. PubMed ID: 26423531
[TBL] [Abstract][Full Text] [Related]
7. The impact of intra-clonal heterogeneity on the treatment of multiple myeloma.
Brioli A; Melchor L; Cavo M; Morgan GJ
Br J Haematol; 2014 May; 165(4):441-54. PubMed ID: 24580032
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma: a paradigm for translation of the cancer stem cell hypothesis.
Agarwal JR; Matsui W
Anticancer Agents Med Chem; 2010 Feb; 10(2):116-20. PubMed ID: 20184542
[TBL] [Abstract][Full Text] [Related]
9. Targeting Multiple Myeloma Cancer Stem Cells with Natural Products - Lessons from Other Hematological Malignancies.
Issa ME; Cretton S; Cuendet M
Planta Med; 2017 Jun; 83(9):752-760. PubMed ID: 28472843
[TBL] [Abstract][Full Text] [Related]
10. Fact or fiction--identifying the elusive multiple myeloma stem cell.
Kellner J; Liu B; Kang Y; Li Z
J Hematol Oncol; 2013 Dec; 6():91. PubMed ID: 24314019
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma.
Yang WC; Lin SF
Biomed Res Int; 2015; 2015():341430. PubMed ID: 26649299
[TBL] [Abstract][Full Text] [Related]
12. Contemporary drug therapies for multiple myeloma.
de la Puente P; Azab AK
Drugs Today (Barc); 2013 Sep; 49(9):563-73. PubMed ID: 24086952
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells in multiple myeloma.
Ghosh N; Matsui W
Cancer Lett; 2009 May; 277(1):1-7. PubMed ID: 18809245
[TBL] [Abstract][Full Text] [Related]
14. Co-evolution of tumor and immune cells during progression of multiple myeloma.
Liu R; Gao Q; Foltz SM; Fowles JS; Yao L; Wang JT; Cao S; Sun H; Wendl MC; Sethuraman S; Weerasinghe A; Rettig MP; Storrs EP; Yoon CJ; Wyczalkowski MA; McMichael JF; Kohnen DR; King J; Goldsmith SR; O'Neal J; Fulton RS; Fronick CC; Ley TJ; Jayasinghe RG; Fiala MA; Oh ST; DiPersio JF; Vij R; Ding L
Nat Commun; 2021 May; 12(1):2559. PubMed ID: 33963182
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Resistance in Multiple Myeloma.
Papadas A; Asimakopoulos F
Handb Exp Pharmacol; 2018; 249():251-288. PubMed ID: 28315070
[TBL] [Abstract][Full Text] [Related]
16. IQGAP1 Scaffold-MAP Kinase Interactions Enhance Multiple Myeloma Clonogenic Growth and Self-Renewal.
Gocke CB; McMillan R; Wang Q; Begum A; Penchev VR; Ali SA; Borrello I; Huff CA; Matsui W
Mol Cancer Ther; 2016 Nov; 15(11):2733-2739. PubMed ID: 27573425
[TBL] [Abstract][Full Text] [Related]
17. Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma.
Ria R; Vacca A
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963513
[TBL] [Abstract][Full Text] [Related]
18. Getting to the root of the problem: the causes of relapse in multiple myeloma.
Chan Chung KC; Tiedemann RE
Expert Rev Anticancer Ther; 2014 Mar; 14(3):251-4. PubMed ID: 24397833
[TBL] [Abstract][Full Text] [Related]
19. Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma.
Hajek R; Okubote SA; Svachova H
Br J Haematol; 2013 Dec; 163(5):551-64. PubMed ID: 24111932
[TBL] [Abstract][Full Text] [Related]
20. Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma.
Manier S; Kawano Y; Bianchi G; Roccaro AM; Ghobrial IM
Curr Opin Hematol; 2016 Jul; 23(4):426-33. PubMed ID: 27101529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
